Clinical Trial

Transorbital Ultrasound and Other Markers for Prognosis Prediction After Cardiac Arrest

Study acronym: TOMCAT
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
In sudden cardiac arrest patients with return of spontaneous circulation, brain damage is one of the main determinants of short-term mortality and poor prognosis (CPC 3-5). It is important to properly select group of patients in whom treatment is futile. According to current guidelines, multimodal approach is recommended. Optic nerve sheath diameter measured by ultrasound is non-invasive, fast, low-cost and readily available bed-side method, but evidence for its use as neuroprognostication modality is limited to only few small studies. The aim of this study is to evaluate validity of ONSD as neuroprognostication method at larger cohort of patients, compare it with other established methods and compare ultrasound and CT measurement of ONSD.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2021-04-06; most recent amendment 2026-04-08.
Status change: Recruiting → Active, Not Recruiting 2024-05-09
Trial Details
NCT Number NCT04838418
Lead Sponsor University Hospital Pilsen
Collaborators: Na Homolce Hospital
Conditions Cardiac Arrest
Enrollment 80 participants
Start Date 2021-01-04
Primary Completion 2026-12-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-09